In 20 years cell and gene therapies for cancer will be commonplace

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/65/f0/eb/65f0eb8a-858c-77f4-8bae-176839c90b3b/mza_3945228970909391865.jpg/600x600bb.jpg

Building the Future

Kadans Science Partner

12 episodes

6 months ago

What will the world look like in 20 years? Will we still be eating meat? What role will robots play in our lives? How soon will we really have a fully self-driving car? In Building the Future, various experts discuss how they see the future. They will talk about the latest innovations, explore the social debate and try to create a picture of the future. Because no matter what we think, fact is that the world is changing. Therefore collaboration is essential for innovation. Want to know more about how Kadans builds the future together with companies?

Visit: www.kadans.com/podcast

Building the Future is brought to you by Kadans Science Partner and is produced by Audio agency Airborne.

All content for Building the Future is the property of Kadans Science Partner and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Technology,

Social Sciences

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/d9d6ce69dec636586ec28e5058c100ae.jpg

In 20 years cell and gene therapies for cancer will be commonplace

Building the Future

41 minutes

4 years ago

In 20 years cell and gene therapies for cancer will be commonplace

Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to treat it, and the experimental techniques being used now may be commonplace in the future. At least, that’s what many experts think.

Host Rudy van Beurden has invited three guests who are experts in this field: Jacqueline Barry, Chief Clinical Officer at CT Catapult; Erik Manting, CEO at Immunicum AB and Trudy Straetemans, Assistant Professor at UMC Utrecht.

Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast.kadans, cancer, cell therapy, gene therapy, disease, experimental

Building the Future is brought to you by Kadans Science Partner.